Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
Sebastian Stintzing(Humboldt-Universität zu Berlin), Heinz‐Josef Lenz(USC Norris Comprehensive Cancer Center), Sabine Tejpar(KU Leuven), Peter Gibbs(The University of Melbourne), Lars Thiebach(Roche (Switzerland))
Cited by 293
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.2k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
|The Lancet Oncology|2017|2.8k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2018|2.1k